Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Gastrointestinal Neoplasms 3Stomach Neoplasms 2Neoplasms 2Esophageal Neoplasms 2Urinary Bladder Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pituitary Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1Appendiceal Neoplasms 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 27Cisplatin 17Oxaliplatin 16Cytoreduction Surgical Procedures 15Paclitaxel 12Fluorouracil 10Mitomycin 8Leucovorin 8Doxorubicin 7Docetaxel 5Neoadjuvant Therapy 4Blood Specimen Collection 4Taxes 3Surgical Procedures, Operative 3Chemotherapy, Adjuvant 3Carboplatin 3Bevacizumab 3catumaxomab 2Platinum 2Palliative Care 2Observation 2Nivolumab 2Mitozytrex 2Laparoscopy 2Interviews as Topic 2Indocyanine Green 2Folfox protocol 2Albumin-Bound Paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Peritoneal Neoplasms × Pafolacianine × Clear all
NCT06511037 2026-02-27

PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis

University of California, Irvine

Phase EARLY_PHASE1 Recruiting
10 enrolled
GastrointestinalGynecologic

Gastrointestinal Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡